Emmaus Life Sciences Inc (EMMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,127 | 1,389 | 2,547 | 2,021 | 2,279 |
| Receivables | 2,804 | 2,623 | 5,524 | 375 | 1,040 |
| Inventories | 1,555 | 1,635 | 1,711 | 2,379 | 4,392 |
| TOTAL | $7,746 | $6,767 | $11,509 | $6,289 | $9,091 |
| Non-Current Assets | |||||
| PPE Net | 113 | 46 | 59 | 75 | 147 |
| Investments And Advances | 12,604 | 15,037 | 20,978 | 38,799 | 43,716 |
| Other Non-Current Assets | 973 | 1,752 | 2,633 | 3,062 | 3,780 |
| TOTAL | $13,690 | $16,835 | $23,670 | $41,936 | $47,643 |
| Total Assets | $21,436 | $23,602 | $35,179 | $48,225 | $56,734 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 17,380 | 17,014 | 451 | 3,248 | 400 |
| Accounts payable and accrued liabilities | 22,615 | 16,926 | 16,951 | 13,549 | 9,189 |
| Other current liabilities | 17,578 | 16,565 | 14,746 | 12,987 | 5,907 |
| TOTAL | $69,072 | $63,555 | $61,507 | $54,323 | $37,100 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,271 | 2,246 | N/A | 380 | 1,500 |
| Other Non-Current Liabilities | 13,701 | 14,280 | 21,428 | 27,613 | 39,584 |
| TOTAL | $15,972 | $16,526 | $21,428 | $27,993 | $41,084 |
| Total Liabilities | $85,044 | $80,081 | $82,935 | $82,316 | $78,184 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 70,188 | 63,866 | 61,846 | 50,935 | 49,312 |
| Common Shares | 70 | 64 | 62 | 50 | 49 |
| Retained earnings | -270,067 | -262,575 | -256,122 | -252,337 | -241,266 |
| Other shareholders' equity | -19,598 | -19,864 | -17,029 | -2,619 | -255 |
| TOTAL | $-63,608 | $-56,479 | $-47,756 | $-34,091 | $-21,450 |
| Total Liabilities And Equity | $21,436 | $23,602 | $35,179 | $48,225 | $56,734 |